IBOGF (Universal Ibogaine) 14-Day RSI: 51.19 (As of Jul. 11, 2026)


What is Universal Ibogaine 14-Day RSI?

Universal Ibogaine IBOGF -1.07% 14-Day RSI is 51.19 as of Jul. 11, 2026.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2026-07-11), Universal Ibogaine's 14-Day RSI is 51.19.

The industry rank for Universal Ibogaine's 14-Day RSI or its related term are showing as below:

IBOGF's 14-Day RSI is not ranked
in the Biotechnology industry.
Industry Median: 48.885 vs IBOGF: 51.19

Universal Ibogaine  (OTCPK:IBOGF) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.

Universal Ibogaine 14-Day RSI Related Terms

IBOGF vs LABT, CALC, LNAI: 14-Day RSI Comparison

For the Biotechnology subindustry, Universal Ibogaine's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universal Ibogaine 14-Day RSI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's 14-Day RSI falls into.


Universal Ibogaine  (OTCPK:IBOGF) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100–[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 14-Day RSI →
What does a 14-Day RSI of 51.19 mean?
Universal Ibogaine (IBOGF) has a 14-Day RSI of 51.19 as of Jul. 11, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Universal Ibogaine and its competitors.
Is Universal Ibogaine's 14-Day RSI too high?
Universal Ibogaine's current 14-Day RSI is 51.19. The Biotechnology industry median 14-Day RSI is 48.89. Universal Ibogaine's value of 51.19 is 4.7% above this industry median.
How does Universal Ibogaine's 14-Day RSI compare to LABT and CALC?
Universal Ibogaine's 14-Day RSI of 51.19 can be compared against companies in the Biotechnology industry. The industry median 14-Day RSI is 48.89. Universal Ibogaine's value of 51.19 is 4.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Biotechnology company?
The median 14-Day RSI among Biotechnology companies is 48.89, based on 1,420 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Universal Ibogaine's current 14-Day RSI of 51.19 is 4.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Universal Ibogaine and its competitors. For the Biotechnology industry, the median 14-Day RSI is 48.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Universal Ibogaine's current 14-Day RSI is 51.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Ibogaine stock overvalued right now?
Universal Ibogaine (IBOGF) has a current 14-Day RSI of 51.19. The current 14-Day RSI is 51.19 and 4.7% above the Biotechnology industry median of 48.89. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Universal Ibogaine (IBOGF), the current 14-Day RSI is 51.19 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Universal Ibogaine Business Description

Address C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.